FDA Biosimilar Approval Process: Understanding Biologic Alternatives in 2026
The FDA's updated 2025 guidelines streamline biosimilar approval, cutting development costs and speeding up access to lower-cost biologic drugs. Learn how the process works, why U.S. adoption lags behind Europe, and what changes mean for patients and healthcare costs.